🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ryan C. Winger

ORCID: 0000-0001-9160-6646
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome”.

The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104143
N/A
0.650DataRank · unranked
16 citations

Le H. Hua, Ellen M. Mowry, Susan A. Gauthier, Enrique Álvarez, Anne H. Cross +6 more

Hybrid and vaccine‐induced immunity against SAR‐CoV ‐2 in MS patients on different disease‐modifying therapies

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51664
N/A
0DataRank · unranked
14 citations

Ryan Curtin, Jinglan Pei, Katherine Perdomo, Tamar Bacon, Iryna Voloshyna +18 more

Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study

medRxiv(2022)10.1101/2022.01.10.22268752
N/A
0DataRank · unranked
5 citations

Y. Patskovsky, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Zoe Rimler +20 more

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51745
N/A
0DataRank · unranked
8 citations

Haley Simpson, Eric Engebretson, Stefan Sillau, Brooke Valdez, José Parra‐González +15 more